PATENT CLAIM ANALYSIS

Application Number: 16206390
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "254110"]

Abstract:
A method of increasing the insulin sensitivity of a mammalian cell by contacting the cell with a protein phosphatase 2A (PP2A) inhibitor having the structure (I).

Claim (Index 79):
The method of  claim 65 , wherein the protein phosphatase 2A inhibitor has the structure

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.29167
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14408475', '12069147', '13866854', '14328384', '16018924']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7588016062840982
- 35 USC 102 Novelty (BERT): 0.5725453564251888
- Combined Prediction Score: 0.7401759812982073
- Mean Citation Score: 369.878716
- Max Citation Score: 506.90887
- Similarity Product: 324.3635375757086

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test